Constitutive phosphorylation of AKT is higher among patients with CLL at high risk for RT transformation (i.e., CLL with NOTCH1 mutation, aggressive CLL with TP53 disruption) (53). Here, TP53 is linked to B-cell chronic lymphocytic leukemia.